Chemotherapy Administration SOP: Safety & Handling Protocols

Standard Operating Procedure: Safe Administration of Chemotherapy

This Standard Operating Procedure (SOP) outlines the mandatory clinical requirements, safety protocols, and administrative workflows for the preparation and administration of chemotherapy agents. Given the high-alert nature of these medications, this document prioritizes patient safety, caregiver protection, and the prevention of medication errors through a rigorous "double-check" verification system. Strict adherence to these steps is required to maintain compliance with oncology nursing standards and hazardous drug handling regulations (USP <800>).

1. Pre-Administration Preparation and Verification

• Verification of Orders: Ensure the oncology provider has signed the chemotherapy order. Confirm that the dosage is calculated based on current height, weight, and Body Surface Area (BSA).
• Lab Review: Review the patient’s most recent Complete Blood Count (CBC) and Comprehensive Metabolic Panel (CMP). Ensure ANC (Absolute Neutrophil Count), platelets, and organ function (liver/renal) are within acceptable ranges per protocol.
• Informed Consent: Confirm that the patient has a signed, valid informed consent form on file for the specific treatment regimen.
• Patient Identification: Use two patient identifiers (Full Name and Date of Birth) to confirm identity against the Electronic Health Record (EHR).
• PPE Procurement: Don appropriate Personal Protective Equipment (PPE) for handling hazardous drugs, including chemotherapy-rated gloves (double-gloving), non-permeable gowns, and eye protection as necessary.

2. Drug Handling and Verification

• Independent Double-Check: A second oncology-certified nurse or pharmacist must verify the drug, dose, route, and expiration date against the patient's chart. Both staff members must sign off on the administration record.
• Label Integrity: Inspect each medication bag for leaks, precipitates, or discoloration. Ensure labels clearly state the drug name, concentration, and patient name.
• Spill Kit Readiness: Verify that a chemotherapy spill kit is immediately accessible in the treatment area before any drugs are removed from the transport container.

3. Patient Assessment and IV Access

• IV Site Patency: Inspect the venous access device (VAD). For peripheral lines, verify clear blood return. For central lines (PICC/Port), confirm placement and flushing protocols are met.
• Extravasation Risk Assessment: Assess the integrity of the vessel to be used. If any signs of infiltration (swelling, pain, erythema) are present, do not initiate infusion.
• Pre-Medication Administration: Administer prescribed antiemetics, corticosteroids, or antihistamines at the specified time intervals prior to starting the chemotherapy agent.

4. Infusion and Monitoring

• Initiation: Use closed-system transfer devices (CSTD) if available. Infuse the drug via a dedicated primary line or a piggyback configuration, following facility policies regarding "line flushing" and compatibility.
• Continuous Surveillance: Monitor the patient for immediate hypersensitivity reactions (chills, dyspnea, hypotension, urticaria). Stay with the patient during the initial 15 minutes of the infusion.
• Documentation: Record the start time, rate of infusion, and nurse signatures in the medication administration record (MAR).

5. Post-Administration and Waste Management

• Line Flushing: Flush the IV line with the recommended volume of compatible IV fluid to ensure the full dose has been delivered.
• Hazardous Waste Disposal: Place all used syringes, IV bags, and tubing into designated "Chemotherapy Waste" (yellow or black) containers.
• Final Assessment: Re-assess the patient for any delayed side effects before discharge. Provide clear instructions on symptoms that require immediate emergency intervention.

Pro Tips & Pitfalls

• Pro Tip: Always calculate the dose yourself before checking it against the pharmacy's calculation. Never rely solely on the machine or another colleague’s math.
• Pro Tip: If a drug requires a vesicant, perform a "dry run" with a saline flush to ensure perfect venous access before connecting the chemo line.
• Pitfall: Do not rush the "Double-Check." Most errors occur during high-volume periods when nurses feel pressured to speed up the verification process.
• Pitfall: Never ignore a patient’s report of "burning" or "tingling" at the site. Stop the infusion immediately—do not flush—if extravasation is suspected.

Template Document: Chemotherapy Administration SOP: Safety & Handling Protocols

This standard operating procedure outlines the mandatory safety protocols and clinical steps for the administration of chemotherapy agents to ensure patient safety and staff protection. It is intended for use by oncology nurses, pharmacists, and clinical support staff involved in the chemotherapy delivery process.

• Document owner: [Department Name]
• Effective date: [Date]
• Version: [Version number]
• Applies to: [Facility or Unit Name]

Roles and responsibilities

Steps

1. Verify the patient identity using [Number] unique identifiers before beginning any preparation.
2. Confirm that the patient has signed the [Name of Consent Form] and that all baseline laboratory results are within the required [Threshold] range.
3. Don the appropriate personal protective equipment, including [Type of Gloves] and [Type of Gown], prior to handling any chemotherapy agents.
4. Perform an independent double-check with a second qualified clinician to verify the drug name, dose, and infusion rate against the [Name of Order System].
5. Inspect the IV site for signs of infiltration or phlebitis and ensure the catheter is patent with a blood return of at least [Amount].
6. Prime the IV tubing with [Type of Solution] and attach the chemotherapy bag using a closed-system transfer device.
7. Program the infusion pump to the specific [Rate] and [Duration] as prescribed in the treatment plan.
8. Monitor the patient for hypersensitivity reactions every [Time Interval] throughout the duration of the infusion.
9. Stop the infusion immediately if the patient reports [Symptom] or if there is any evidence of extravasation.
10. Dispose of all chemotherapy-contaminated materials, including tubing and vials, into the designated [Color] hazardous waste container.
11. Document the administration details, including the start time, end time, and any adverse events, in the [Name of Electronic Record].
12. Flush the IV line with [Amount] of saline upon completion to ensure the full dose is delivered and to clear the tubing.

Record of completion

• Prepared by: [Full name]
• Reviewed by: [Full name]
• Date completed: [Date]
• Signature: ______________________
• Date signed: [Date]

Frequently Asked Questions (FAQ)

Q: What should I do if the drug bag appears cloudy? A: Do not administer the medication. Immediately return the bag to the pharmacy for inspection and documentation. The drug may have precipitated or undergone chemical degradation.

Q: Can I infuse chemotherapy and other non-chemo medications concurrently? A: Generally, no. Chemotherapy should be administered through a dedicated line to avoid drug-drug interactions and to ensure that in the event of an extravasation or reaction, you are not administering other agents simultaneously.

Q: How long must I keep the patient under observation after the infusion? A: Observation requirements vary by drug protocol. However, it is standard practice to monitor for at least 30 to 60 minutes post-infusion for delayed hypersensitivity, depending on the specific regimen and the patient’s history.